March 6, 2009 – VectraCor Inc. submitted its 510(k) application to the FDA in December for a new technology to derive 22-lead ECG function from only five electrodes

Researchers at the Section of Cardiology, Department of Medicine, University of Chicago Hospitals said their findings, published in the March 1 issue of the American Journal of Cardiology, Vol. 103, Issue 5, suggest SPECT perfusion imaging should be conducted on patients who have abnormal heart rate recovery (HRR) on routine exercise treadmill testing.

March 6, 2009 – New research published in the March edition of the HeartRhythm Journal reveals that black and Hispanic patients who were eligible for cardiac resynchronization therapy with defibrillator (CRT-D) were less likely to receive therapy than eligible white patients.

March 5, 2009 - Bristol-Myers Squibb Company yesterday said it is collaborating with Nissan Chemical Industries Ltd. and Teijin Pharma Ltd.

March 5, 2009 - CorMatrix Cardiovascular Inc., developer of extracellular matrix (ECM Technology) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, announced the first implant in Europe of the CorMatrix ECM Technology in a patient undergoing cardiac surgery.

March 5, 2009 - Prescient Medical Inc. announced it completed enrollment in February of 30 patients in the first phase of its first-in-human clinical trial for the vProtect Luminal Shield, conducted at the Corbic Research Institute in Colombia.

March 5, 2009 - Reducing the frequency and severity of disabling migraines is crucial for quality of life and a new study, published in the February 2009 issue of JACC: Cardiovascular Interventions, finds significant improvement of migraines following catheter-based closure of patent foramen ovale (PFO).